LOPERAMIDE HCI - Superior Pharmaceutical Grade Treatment for Acute and Chronic Diarrhea
ProcurenetShort description
Pharmaceutical Grade LOPERAMIDE HCI – Efficient Antidiarrheal Treatment
This product features LOPERAMIDE HCI, an active ingredient recognized for its efficacy in diarrhea management. It operates on the mu-opioid receptors in the gut, effectively decreasing bowel motility and enhancing absorption of water and electrolytes. Key product highlights:
- High-quality grades available: Drug Master File/USDMF/EDMF
- Multiple origin variants
- Technical support provided
- Immediate stock availability ensuring quick delivery
Supplemented with inactive ingredients for reliable stability, this LOPERAMIDE HCI is a trusted solution for diarrhea treatment. Store in a cool, dry area, and adhere to usage guidelines set by your healthcare practitioner. Reach out to us for any queries.
-
Procurenet Team Tshim Sha Tsui
Hong Kong
3 years
Description
LOPERAMIDE HCI - Top-Tier Pharmaceutical Grade Antidiarrheal Solution
An industry-leading solution, LOPERAMIDE HCI is widely renowned in the pharmaceutical world for providing speedy and effective relief from both acute and chronic diarrhea types. Available in superior grades including Drug Master File/USDMF/EDMF, this compound is highly efficient in reducing stool frequency and bringing about swift comfort to users.
- Synonyms: Imodium, R-18553
- IUPAC Name: 4-[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]-N,N-dimethyl-2,2-diphenylbutanamide
- CAS Number: 34552-83-5
- Molecular Formula: C29H33ClN2O2
- Molecular Weight: 477.037 g/mol
- Density: 1.1±0.1 g/cm3 (Predicted)
- pH: 5.8 – 7.2 (100g/L, H2O, 20℃)
- LogP: 5.43
- Hazard and Precautionary Statements: Ensure this compound is kept out of the reach of children. It is not designed for long-term usage. Never exceed the recommended dosage.
- Pharmacological Class: Antidiarrheal
- Therapeutic Uses: Efficient in controlling and providing symptomatic relief from acute nonspecific diarrhea and chronic diarrhea associated with inflammatory bowel disease.
- Dosage: The prescribed adult oral dosage is 4mg initially, followed by an additional 2mg intake after every unformed stool. Do not exceed 16mg per day.
- Contraindications: Not recommended for patients with known hypersensitivity to loperamide or in cases where constipation must be avoided.
- Side Effects: Dizziness, nausea, constipation, exhaustion, and abdominal discomfort may occur.
Note: A comprehensive medical assessment should be conducted prior to commencing any new medication. LOPERAMIDE HCI is not a replacement for rehydration therapy.
